Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Prostate Cancer

Free Subscription Articles published in Urology Retrieve available abstracts of 95 articles: HTML format

Single Articles

November 2022
1. SIAPNO AED, Gaither TW, Tandel MD, Kwan L, et al
   Impact of Comprehensive Health Insurance on Quality of Life in Low-Income Hispanic Men with Prostate Cancer.
   Urology. 2022 Nov 15. pii: S0090-4295(22)00954.
   PubMed     Abstract available
   
   
   
2. MANN RA, Kasabwala K, Buckley JC, Smith TG, et al
   The "Fragile" Urethra as a Predictor of Early Artificial Urinary Sphincter Erosion.
   Urology. 2022;169:233-236.
   PubMed     Abstract available
   
   
   October 2022
3. KANABOLO D, True L, Vakar-Lopez F, Tretiakova M, et al
   Prostate-specific Antigen (PSA) Screening and a Lifesaving Cardiac Transplant.
   Urology. 2022;168:e1-e2.
   PubMed    
   
   
   
4. MORRISON JC, Sax-Bolder A, Gershman B, Konety B, et al
   Geographic Variation of Infectious Complications Following Prostate Biopsy in The United States: Results From a Population-Based Cohort of Privately Insured Patients.
   Urology. 2022;168:27-34.
   PubMed     Abstract available
   
   
   September 2022
5. CHOE S, Patel HD, Lanzotti N, Okabe Y, et al
   MRI vs Transrectal Ultrasound to Estimate Prostate Volume and PSAD: Impact on Prostate Cancer Detection.
   Urology. 2022 Sep 21. pii: S0090-4295(22)00806.
   PubMed     Abstract available
   
   
   
6. IMBER BS, O'Dwyer E, Lobaugh S, McBride SM, et al
   Failure patterns by PSMA PET for recurrent prostate cancer after prostatectomy and salvage radiation.
   Urology. 2022 Sep 14. pii: S0090-4295(22)00779.
   PubMed     Abstract available
   
   
   
7. HUANG D, Yang X, Liu Y, Huang Z, et al
   Prostate Cancer presenting as a solitary sacral osteolytic metastasis mimicking chordoma on (18)F-FDG PET/CT.
   Urology. 2022 Sep 14. pii: S0090-4295(22)00798.
   PubMed    
   
   
   
8. INOUYE BM, Krischak MK, Krughoff K, Boysen WR, et al
   Resection of Pubic Symphysis and Cystectomy Significantly Improves Short-Term Patient-Reported Physical Functioning Among Patients With Pubovesical Fistula and Pubic Bone Osteomyelitis.
   Urology. 2022;167:218-223.
   PubMed     Abstract available
   
   
   
9. MOVASSAGHI M, Ahmed F, Patel H, Luk L, et al
   Association of Patient and Imaging-Related Factors With False Negative MRI-Targeted Prostate Biopsies of Suspicious PI-RADS 4 and 5 Lesions.
   Urology. 2022;167:165-170.
   PubMed     Abstract available
   
   
   August 2022
10. HARRINGTON SA, Fialk G, Raman JD
    RE: "Transperineal Prostate Biopsy is Associated With Lower Tissue Core Pathogen Burden Relative to Transrectal Biopsy: Mechanistic Underpinnings for Lower Infection Risk in the Transperineal Approach".
    Urology. 2022;166:297-298.
    PubMed    
    
    
    July 2022
11. OKABE Y, Patel HD, Rac G, Gupta GN, et al
    Multifocality of Prostate Cancer and Candidacy for Focal Therapy Based on Magnetic Resonance Imaging.
    Urology. 2022 Jul 29. pii: S0090-4295(22)00631.
    PubMed     Abstract available
    
    
    
12. NASSIRI N, Richardson S, Kuppermann D, Brisbane WG, et al
    Partial gland ablation of prostate cancer: Effects of Repeat Treatment.
    Urology. 2022 Jul 27. pii: S0090-4295(22)00617.
    PubMed     Abstract available
    
    
    
13. CALLEJAS MF, Klein EA, Truong M, Thomas L, et al
    Detection of clinically significant index prostate cancer using micro-ultrasound: correlation with radical prostatectomy.
    Urology. 2022 Jul 14. pii: S0090-4295(22)00592.
    PubMed     Abstract available
    
    
    
14. DE BARROS HA, Remmers S, Luiting HB, van Leenders GJLH, et al
    Predictive value of Cribriform and Intraductal Carcinoma for the Nomogram-Based Selection of Prostate Cancer Patients for Pelvic Lymph Node Dissection.
    Urology. 2022 Jul 5. pii: S0090-4295(22)00537.
    PubMed     Abstract available
    
    
    
15. WERNEBURG GT, Adler A, Zhang A, Mukherjee SD, et al
    Transperineal Prostate Biopsy is Associated With Lower Tissue Core Pathogen Burden Relative to Transrectal Biopsy: Mechanistic Underpinnings for Lower Infection Risk in the Transperineal Approach.
    Urology. 2022;165:1-8.
    PubMed     Abstract available
    
    
    
16. HARRISON R, Stifelman M, Billah M, Zaifman J, et al
    Propensity-Score Matched Analysis Between Extraperitoneal Single Port and Intraperitoneal Multiport Radical Prostatectomy: A Single-Institutional Experience.
    Urology. 2022;165:198-205.
    PubMed     Abstract available
    
    
    
17. LANE GI, Qi J, Dupati A, Ferrante S, et al
    Assessing the Impact of Decision Aid Use on Post Prostatectomy Patient Reported Outcomes.
    Urology. 2022;165:187-192.
    PubMed     Abstract available
    
    
    
18. SLOPNICK EA, Bagby C, Mahran A, Nagel C, et al
    Skene's Gland Malignancy: A Case Report and Systematic Review.
    Urology. 2022;165:36-43.
    PubMed     Abstract available
    
    
    June 2022
19. DELANEY RK, Sisco-Taylor BL, Wang X, Scherr K, et al
    Two Specialists, Two Recommendations: Discordance between Urologists' & Radiation Oncologists' Prostate Cancer Treatment Recommendations.
    Urology. 2022 Jun 26. pii: S0090-4295(22)00512.
    PubMed     Abstract available
    
    
    
20. BENIDIR T, Hofmann M, Lone Z, Nguyen JK, et al
    Elevated IsoPSA Selects for Clinically Significant Prostate Cancer Without a Preference for Any Particular Adverse Histopathologic or Radiographic Feature.
    Urology. 2022 Jun 6. pii: S0090-4295(22)00449.
    PubMed     Abstract available
    
    
    
21. JEONG SH, Werneburg GT, Abouassaly R, Wood H, et al
    Acquired and Congenital Spinal Cord Injury is Associated With Lower Likelihood of Prostate Specific Antigen Screening.
    Urology. 2022;164:178-183.
    PubMed     Abstract available
    
    
    
22. CHIU PKF, Ahmed HU, Rastinehad AR
    TRUS Biopsy vs Transperineal Biopsy for Suspicion of Prostate Cancer.
    Urology. 2022;164:18-20.
    PubMed    
    
    
    
23. TOSOIAN JJ, Singhal U, Davenport MS, Wei JT, et al
    Urinary MyProstateScore (MPS) to Rule out Clinically-Significant Cancer in Men with Equivocal (PI-RADS 3) Multiparametric MRI: Addressing an Unmet Clinical Need.
    Urology. 2022;164:184-190.
    PubMed     Abstract available
    
    
    April 2022
24. GOLDENTHAL SB, Reimers MA, Singhal U, Farha M, et al
    Prostate Cancer with Peritoneal Carcinomatosis: A robotic-assisted radical prostatectomy-based Case Series.
    Urology. 2022 Apr 23. pii: S0090-4295(22)00296.
    PubMed     Abstract available
    
    
    March 2022
25. PINO MD, Abern MR, Moreira DM
    Prostate Cancer Disparities in Hispanics using the National Cancer Database.
    Urology. 2022 Mar 26. pii: S0090-4295(22)00256.
    PubMed     Abstract available
    
    
    
26. LOWENTRITT B, Brown G, Pilon D, Ellis L, et al
    Real-World Prostate-Specific Antigen Response and Treatment Adherence of Apalutamide in Patients with Non-Metastatic Castration-Resistant Prostate Cancer.
    Urology. 2022 Mar 19. pii: S0090-4295(22)00245.
    PubMed     Abstract available
    
    
    
27. NASRI J, Barthe F, Parekh S, Ratnani P, et al
    Nomogram predicting adverse pathology outcome on radical prostatectomy in low-risk prostate cancer men.
    Urology. 2022 Mar 6. pii: S0090-4295(22)00173.
    PubMed     Abstract available
    
    
    
28. KUPERUS JM, Tobert CM, Semerjian AM, Qi J, et al
    Pelvic Lymph Node Dissection at Radical Prostatectomy for Intermediate Risk Prostate Cancer: Assessing Utility and Nodal Metastases Within a Statewide Quality Improvement Consortium.
    Urology. 2022 Mar 6. pii: S0090-4295(22)00166.
    PubMed     Abstract available
    
    
    
29. BEARRICK EN, Findlay BL, Maciejko LA, Hebert KJ, et al
    Robotic Urethral Reconstruction Outcomes in Men With Posterior Urethral Stenosis.
    Urology. 2022;161:118-124.
    PubMed     Abstract available
    
    
    February 2022
30. MASON MM, Nackeeran S, Lokeshwar SD, Blachman-Braun R, et al
    PSA Testing in Men Receiving Testosterone Therapy with History of Prostate Cancer: A Matched Analysis of a Large Multi-Institutional Research Network.
    Urology. 2022 Feb 25. pii: S0090-4295(22)00161.
    PubMed     Abstract available
    
    
    
31. LIM M, Qureshi MM, Boyd G, Hirsch AE, et al
    Effect of Radiation Treatment at a High-Volume Center on Outcomes in Intermediate-Risk Prostate Cancer: An Analysis of the National Cancer Database.
    Urology. 2022 Feb 16. pii: S0090-4295(22)00144.
    PubMed     Abstract available
    
    
    
32. HACKER EC, Maganty A, Pere MM, Rusilko PJ, et al
    Outcomes of Vesicourethral Anastomotic Stenosis and Bladder Neck Contracture with Direct Visual Internal Urethrotomy with Mitomycin-C After Prostate Cancer Treatment.
    Urology. 2022 Feb 12. pii: S0090-4295(22)00110.
    PubMed     Abstract available
    
    
    
33. LAVI A, Yudkevich B, Pechansky S, Tzemach S, et al
    Author Reply.
    Urology. 2022;160:159.
    PubMed    
    
    
    January 2022
34. VERSALLE D, Qi J, Noyes S, Moriarity A, et al
    Practice-level variation in the decision to biopsy PI-RADS 3 lesions in favorable-risk prostate cancer patients.
    Urology. 2022 Jan 23. pii: S0090-4295(22)00070.
    PubMed     Abstract available
    
    
    
35. KOTAMARTI S, George A, Zhu A, Polascik TJ, et al
    Transrectal Ultrasound-Guided Biopsy Should Continue to Be a Standard of Care for The Detection of Prostate Cancer.
    Urology. 2022 Jan 14. pii: S0090-4295(22)00018.
    PubMed     Abstract available
    
    
    
36. ROEBUCK E, Sha W, Lu C, Miller C, et al
    Racial and Socioeconomic Disparities in MRI-Fusion Biopsy Utilization to Assess for Prostate Cancer.
    Urology. 2022 Jan 4. pii: S0090-4295(21)01201.
    PubMed     Abstract available
    
    
    
37. REDMOND EJ, Doiron RC, Rourke KF
    Development of New Comorbidities in Patients Awaiting Urinary Incontinence Surgery Following Radical Prostatectomy.
    Urology. 2022;159:235-240.
    PubMed     Abstract available
    
    
    December 2021
38. NAKAI Y, Tanaka N, Asakawa I, Miyake M, et al
    Mirabegron reduces urinary frequency and improves overactive bladder symptoms at 3 months after (125)I-brachytherapy for prostate cancer: An open-labeled, randomized, non-placebo-controlled study.
    Urology. 2021 Dec 29. pii: S0090-4295(21)01183.
    PubMed     Abstract available
    
    
    
39. WITTMANN D, Varlamos C, Rodriguez-Galano N, Day L, et al
    Developing a Patient-Centered Model of Prostate Cancer Care: Patient Satisfaction with a Survivorship Program Embedded in Urologic-oncologic Care.
    Urology. 2021 Dec 8. pii: S0090-4295(21)01153.
    PubMed     Abstract available
    
    
    
40. SABA P, Melnyk R, Holler T, Oppenheimer D, et al
    Comparison of Multi-Parametric MRI of the Prostate to 3D Prostate Computer Aided Designs and 3D-Printed Prostate Models for Pre-Operative Planning of Radical Prostatectomies: A Pilot Study.
    Urology. 2021;158:150-155.
    PubMed     Abstract available
    
    
    November 2021
41. LAVI A, Yudkevich B, Pechansky S, Tzemach S, et al
    Implications of a Novel Biopsy Downloading System on Prostate Cancer Detection Rate, Surveillance and Focal Therapy - A Prospective Study.
    Urology. 2021 Nov 12. pii: S0090-4295(21)01039.
    PubMed     Abstract available
    
    
    
42. VERTOSICK EA, Zappala S, Punnen S, Hugosson J, et al
    Individual Patient Data Meta-analysis of Discrimination of the Four Kallikrein Panel Associated With the Inclusion of Prostate Volume.
    Urology. 2021;157:102-106.
    PubMed     Abstract available
    
    
    
43. LORENZ U, Samaseika Y, Balsmeyer U, Neumann N, et al
    Multicystic Prostate Tumor.
    Urology. 2021;157:41.
    PubMed    
    
    
    October 2021
44. SEIDEN B, Weng S, Sun N, Gordon D, et al
    NCCN Risk Reclassification in Black men with low and intermediate risk Prostate Cancer after genomic testing.
    Urology. 2021 Oct 21. pii: S0090-4295(21)00979.
    PubMed     Abstract available
    
    
    
45. SPITZNAGEL T, Hardenberg JV, Schmid FA, Rupp NJ, et al
    Salvage Robotic-assisted Laparoscopic Radical Prostatectomy Following Focal High-Intensity Focused Ultrasound for ISUP 2/3 Cancer.
    Urology. 2021;156:147-153.
    PubMed     Abstract available
    
    
    September 2021
46. ESDAILLE AR, Ibilibor C, Ii AH, Palmer NR, et al
    Access and Representation: A Narrative Review of the Disparities in Access to Clinical Trials and Precision Oncology in Black men with Prostate Cancer.
    Urology. 2021 Sep 25. pii: S0090-4295(21)00893.
    PubMed     Abstract available
    
    
    
47. BERTOLO R, Garisto J, Bove P, Mottrie A, et al
    Perioperative Outcomes Between Single-Port and "Multi-Port" Robotic Assisted Radical Prostatectomy: Where do we stand?
    Urology. 2021;155:138-143.
    PubMed     Abstract available
    
    
    
48. DE LA CALLE CM, Shee K, Chu CE, Cowan JE, et al
    Association of Age With Risk of Adverse Pathological Findings in Men Undergoing Delayed Radical Prostatectomy Following Active Surveillance.
    Urology. 2021;155:91-95.
    PubMed     Abstract available
    
    
    
49. PRESS BH, Khajir G, Ghabili K, Leung C, et al
    Utility of PSA Density in Predicting Upgraded Gleason Score in Men on Active Surveillance With Negative MRI.
    Urology. 2021;155:96-100.
    PubMed     Abstract available
    
    
    
50. SAYYID RK, Klotz L, Benton JZ, Lodh A, et al
    Influence of Sociodemographic Factors on Definitive Intervention Among Low-risk Active Surveillance Patients.
    Urology. 2021;155:117-123.
    PubMed     Abstract available
    
    
    
51. CHECCUCCI E, Piramide F, Amparore D, De Cillis S, et al
    Beyond the Learning Curve of Prostate MRI/TRUS Target Fusion Biopsy after More than 1000 Procedures.
    Urology. 2021;155:39-45.
    PubMed     Abstract available
    
    
    
52. CRICCO-LIZZA E, Wilcox Vanden Berg RN, Laviana A, Pantuck M, et al
    Comparative Effectiveness and Tolerability of Transperineal MRI-Targeted Prostate Biopsy under Local versus Sedation.
    Urology. 2021;155:33-38.
    PubMed     Abstract available
    
    
    
53. LEE AY, Chen K, Law YM, Ho HS, et al
    Robot-assisted Magnetic Resonance Imaging-ultrasound Fusion Transperineal Targeted Biopsy.
    Urology. 2021;155:46.
    PubMed     Abstract available
    
    
    
54. WEI G, Papa N, Kelly B, Bolton D, et al
    Trends in the Uptake of Diagnostic Multi-Parametric MRI of the Prostate With Federal Funding: Australia Population Data.
    Urology. 2021;155:9-11.
    PubMed    
    
    
    
55. BRIGGS LG, Kim M, Gusev A, Rumpf F, et al
    Evaluation of In-Office MRI/US Fusion Transperineal Prostate Biopsy via Free-hand Device during Routine Clinical Practice.
    Urology. 2021;155:26-32.
    PubMed     Abstract available
    
    
    
56. LEVY A, Fleishman A, Jackson M, Waisman A, et al
    Using Preoperative Pelvic Floor Assessment to Predict Early Return of Continence after Robotic Radical Prostatectomy.
    Urology. 2021;155:160-164.
    PubMed     Abstract available
    
    
    
57. ALTOK M, Chapin BF, Matin SF, Achim MF, et al
    Therapeutic Consequences of Omitting a Pelvic Lymph Node Dissection at Radical Prostatectomy when Grade and/or Stage Increase.
    Urology. 2021;155:144-151.
    PubMed     Abstract available
    
    
    
58. MEHTA A, Kim WC, Aswad KG, Brunckhorst O, et al
    Erectile Function Post Prostate Biopsy: A Systematic Review and Meta-analysis.
    Urology. 2021;155:1-8.
    PubMed     Abstract available
    
    
    August 2021
59. BREE KK, Hensley PJ, Pettaway CA
    Germline Mutations in African American Men with Prostate Cancer: Incidence, Implications and Diagnostic Disparities.
    Urology. 2021 Aug 25. pii: S0090-4295(21)00796.
    PubMed     Abstract available
    
    
    
60. POSIELSKI N, Frankel J, Kuo HC, Ho O, et al
    IMPACT OF AGE AND RACE ON HEALTH-RELATED QUALITY OF LIFE OUTCOMES IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY FOR LOCALIZED PROSTATE CANCER.
    Urology. 2021 Aug 21. pii: S0090-4295(21)00783.
    PubMed     Abstract available
    
    
    
61. VINCE RA JR, Jamieson S, Mahal B, Iii WU, et al
    Examining the Racial Disparities in Prostate Cancer.
    Urology. 2021 Aug 18. pii: S0090-4295(21)00772.
    PubMed     Abstract available
    
    
    
62. BERG RNWV, Basourakos SP, Shoag J, Scherr D, et al
    Prostate Cancer Screening for Gay Men in the United States.
    Urology. 2021 Aug 8. pii: S0090-4295(21)00734.
    PubMed     Abstract available
    
    
    
63. JAMIESON SC, Mallory CW, Jivanji DR, Perez A, et al
    THE ROLE OF HEALTH LITERACY IN PROSTATE CANCER SCREENING.
    Urology. 2021 Aug 7. pii: S0090-4295(21)00735.
    PubMed     Abstract available
    
    
    
64. LEWICKI P, Arenas-Gallo C, Basourakos SP, Awamlh BAHA, et al
    Re: Dudith Pierre-Victor, Howard L. Parnes, Gerald L. Andriole, et al. Prostate Cancer Incidence and Mortality Following a Negative Biopsy in a Population Undergoing PSA Screening. Urology 2021 Jun 26;S0090-4295(21)00539-2.
    Urology. 2021 Aug 3. pii: S0090-4295(21)00722.
    PubMed    
    
    
    
65. BORGES DA PONTE C, Leitao TP, Miranda M, Polido J, et al
    Prostate Ewing Sarcoma/PNET: A case of long survival in a highly aggressive malignancy.
    Urology. 2021;154:e11-e12.
    PubMed     Abstract available
    
    
    July 2021
66. DEROUEN MC, Yang J, Jain J, Weden MM, et al
    Disparities in prostate cancer survival according to neighborhood archetypes, a population-based study.
    Urology. 2021 Jul 22. pii: S0090-4295(21)00674.
    PubMed     Abstract available
    
    
    
67. PATEL HD, Doshi CP, Koehne EL, Hart S, et al
    African American Men have Increased Risk of Prostate Cancer Detection despite Similar Rates of Anterior Prostatic Lesions and PI-RADS Grade on Multiparametric Magnetic Resonance Imaging.
    Urology. 2021 Jul 21. pii: S0090-4295(21)00678.
    PubMed     Abstract available
    
    
    
68. SESSINE MS, Das S, Park B, Salami SS, et al
    Initial Findings from a High Genetic Risk Prostate Cancer Clinic.
    Urology. 2021 Jul 16. pii: S0090-4295(21)00647.
    PubMed     Abstract available
    
    
    
69. GAYLIS F, Nasseri R, Salmasi A, Anderson C, et al
    Implementing Continuous Quality Improvement in an Integrated Community Urology Practice: Lessons Learned.
    Urology. 2021;153:139-146.
    PubMed     Abstract available
    
    
    
70. WARNER JN, Gallegos MA
    Letter to the Editor RE: Multi-Institutional Outcomes and Associations after Excision and Primary Anastomosis for Radiotherapy-Associated Bulbomembranous Urethral Stenoses Following Prostate Cancer Treatment.
    Urology. 2021;153:359-360.
    PubMed    
    
    
    
71. SHAH N, Ioffe V
    Re: Letter to the Editor: Generalizability of Prostate-Specific Antigen (PSA) Screening Trials in a "Real World" Setting: A Nationwide Survey Analysis. Deepansh Dalela et al. (Urology 2021;148:1-3).
    Urology. 2021;153:360-361.
    PubMed    
    
    
    June 2021
72. PIERRE-VICTOR D, Parnes HL, Andriole GL, Pinsky PF, et al
    Prostate Cancer Incidence and Mortality Following a Negative Biopsy in a Population Undergoing PSA Screening.
    Urology. 2021 Jun 26. pii: S0090-4295(21)00539.
    PubMed     Abstract available
    
    
    
73. CHANDRASEKAR T, Bowler N, Schneider A, Goldberg H, et al
    Outcomes of Active Surveillance for Men with Intermediate Risk Prostate Cancer, A Population-Based Analysis.
    Urology. 2021 Jun 26. pii: S0090-4295(21)00560.
    PubMed     Abstract available
    
    
    
74. KAWA SM, Stroomberg HV, Larsen SB, Helgstrand JT, et al
    Detection of clinically significant prostate cancer by systematic TRUS-biopsies in a population-based setting over a 20 year period.
    Urology. 2021 Jun 22. pii: S0090-4295(21)00538.
    PubMed     Abstract available
    
    
    
75. CAMPBELL RA, Li J, Malone L, Levy DA, et al
    Correlative Analysis of Vitamin D and Omega-3 Fatty Acid Intake in Men on Active Surveillance for Prostate Cancer.
    Urology. 2021 Jun 15. pii: S0090-4295(21)00525.
    PubMed     Abstract available
    
    
    
76. SOERENSEN SJC, Thomas IC, Schmidt B, Daskivich T, et al
    Reply to the Editorial Comment on: Using an Automated Electronic Health Record Score To Estimate Life Expectancy In Men Diagnosed With Prostate Cancer In The Veterans Health Administration. Urology. 2021.
    Urology. 2021 Jun 14. pii: S0090-4295(21)00488.
    PubMed     Abstract available
    
    
    
77. CHAO B, Lepor H
    5-Year Outcomes Following Focal Laser Ablation of Prostate Cancer.
    Urology. 2021 Jun 3. pii: S0090-4295(21)00460.
    PubMed     Abstract available
    
    
    May 2021
78. HESTERBERG AB, Gordetsky JB, Hurley PJ
    Cribriform Prostate Cancer: Clinical Pathologic and Molecular Considerations.
    Urology. 2021 May 28. pii: S0090-4295(21)00442.
    PubMed     Abstract available
    
    
    
79. KING MC, Sardi A, Velez-Mejia C, Sittig M, et al
    Novel Case of Isolated Peritoneal Carcinomatosis from Metastatic Prostate Cancer Carrying a Pathogenic BRCA Mutation Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Urology. 2021 May 25. pii: S0090-4295(21)00435.
    PubMed     Abstract available
    
    
    
80. ARMSTRONG N, Bahl A, Pinkawa M, Ryder S, et al
    SpaceOAR Hydrogel spacer for reducing radiation toxicity during radiotherapy for prostate cancer. A systematic review.
    Urology. 2021 May 22. pii: S0090-4295(21)00421.
    PubMed     Abstract available
    
    
    
81. SCHUBBE ME, Gellhaus PT, Tobert CM, Mott SL, et al
    Knowledge and Attitudes Regarding Surgical Castration in Men Receiving Androgen Deprivation Therapy for Metastatic Prostate Cancer and Their Relationship to Health-Related Quality of Life.
    Urology. 2021 May 7. pii: S0090-4295(21)00368.
    PubMed     Abstract available
    
    
    
82. KF R
    Re: Multi-Institutional Outcomes and Associations after Excision and Primary Anastomosis for Radiotherapy-Associated Bulbomembranous Urethral Stenoses Following Prostate Cancer Treatment.
    Urology. 2021 May 1. pii: S0090-4295(21)00355.
    PubMed    
    
    
    April 2021
83. PAUDEL R, Ferrante S, Qi J, Dunn RL, et al
    Patient preferences and treatment decisions for prostate cancer: Results from a statewide urological quality improvement collaborative.
    Urology. 2021 Apr 29. pii: S0090-4295(21)00350.
    PubMed     Abstract available
    
    
    
84. NORRIS JM, Ball R, Freeman A, Ghei M, et al
    Patient Perspectives and Understanding of MRI-Directed Prostate Cancer Diagnosis.
    Urology. 2021 Apr 3. pii: S0090-4295(21)00301.
    PubMed    
    
    
    March 2021
85. MADI R, Sayyid RK, Hiffa A, Thomas E, et al
    Early Experience with Salvage Retzius-sparing Robotic-assisted Radical Prostatectomy: Oncologic and Functional Outcomes.
    Urology. 2021;149:117-121.
    PubMed     Abstract available
    
    
    
86. LINDSAY J, Uribe S, Moschonas D, Pavlakis P, et al
    Patient Satisfaction and Regret After Robot-assisted Radical Prostatectomy: A Decision Regret Analysis.
    Urology. 2021;149:122-128.
    PubMed     Abstract available
    
    
    
87. NAITO H, Kato T, Ishikawa R, Tanaka K, et al
    The Impact of Histopathological Features of Prostate Cancerous Lesions on Multiparametric Magnetic Resonance Imaging Findings using PI-RADS Version 2.
    Urology. 2021;149:174-180.
    PubMed     Abstract available
    
    
    
88. WONG D, Rincon J, Henning G, Smith Z, et al
    Retzius Sparing Prostatectomy Effect on Symptomatic Lymphocele Rates.
    Urology. 2021;149:129-132.
    PubMed     Abstract available
    
    
    
89. GUERRIOS-RIVERA L, Howard LE, Klaassen Z, Terris MK, et al
    Do Hispanic Men Have Worse Outcomes After Radical Prostatectomy? Results From SEARCH.
    Urology. 2021;149:181-186.
    PubMed     Abstract available
    
    
    February 2021
90. SAPIENZA LG, Ning MS, Carvalho EF, Spratt D, et al
    Efficacy and Incontinence Rates After Urethroplasty for Radiation-Induced Urethral Stenosis: A Systematic Review and Meta-Analysis.
    Urology. 2021 Feb 22. pii: S0090-4295(21)00190.
    PubMed     Abstract available
    
    
    
91. DALELA D, Sood A, Keeley J, Rogers C, et al
    Generalizability of Prostate-Specific Antigen (PSA) Screening Trials in a "Real World" Setting: A Nationwide Survey Analysis.
    Urology. 2021;148:1-3.
    PubMed    
    
    
    
92. KUBOTA M, Matsuoka T, Yamasaki T, Kokubun H, et al
    Effect of Continued Perioperative Anticoagulant Therapy on Bleeding Outcomes Following Robot-assisted Radical Prostatectomy.
    Urology. 2021;148:151-158.
    PubMed     Abstract available
    
    
    
93. ETAFY MH, Katz JE, Gonzalgo MR, Garcia Lopez EA, et al
    Holmium Laser Enucleation of Prostate Within 6 Weeks of Transrectal Ultrasound Guided Prostate Biopsy is Safe and Effective.
    Urology. 2021;148:88-92.
    PubMed     Abstract available
    
    
    January 2021
94. HUANG MM, Patel HD, Wainger JJ, Su ZT, et al
    Comparison of Perioperative and Pathologic Outcomes Between Single-port and Standard Robot-assisted Radical Prostatectomy: An Analysis of a High-volume Center and the Pooled World Experience.
    Urology. 2021;147:223-229.
    PubMed     Abstract available
    
    
    January 2020
95. PATEL MS, Halpern JA, Desai AS, Keeter MK, et al
    Success of Prostate and Testicular Cancer Awareness Campaigns Compared to Breast Cancer Awareness Month According to Internet Search Volumes: A Google Trends Analysis.
    Urology. 2020 Jan 27. pii: S0090-4295(20)30081.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: